Literatur
-
01
Ludwig H, Van Belle S, Barrett-Lee P. et al .
The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.
European J of Cancer.
2004;
40
2293-2306
-
02 Seidenfeld J, Aronson N, Piper M, Flamm C R, Hasselblad V, Ziegler K M. Uses of Epoetin for Anemia in Oncology. AHRQ Publication No.01-E009 Evidence Report/Technology Assessment, Number 30 Epoetin and Oncology. Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services 2101 East Jefferson Street, Rockville, 2001 MD 20852; http://hstat.nlm.nih.gov/hq/Hquest.
-
03
Crawford J, Cella D, Cleeland C S. et al .
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving Epoetin alfa therapy.
Cancer.
2002;
95
888-95
-
04
Bohlius J, Langensiepen s, Schwarzer G, Seidenfeld J, Piper M, Bennett C, Engert A.
A. Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.
JNCI.
2005;
97
489-498
-
05
Henke M, Laszig R, Rübe C, Schäfer U, Haase K D, Schilcher B, Mose S, Beer K T, Burger U, Dougherty C, Frommhold H.
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.
Lancet.
2003;
362
1255-1260
-
06
Leyland-Jones B.
Breast cancer trial with erythropoietin terminated unexpectedly.
Lancet Oncol.
2003;
4
459-460
-
07
Bokemeyer C, Aapro M S, Courdi A. et al .
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
European J of Cancer.
2004;
40
2201-2216
-
08
Caro J J, Salas M, Ward A. et al .
Anemia as an independent prognostic factor for survival in patients with cancer.
Cancer.
2001;
91
2214-21
-
09
Ludwig H, Fritz E, Kotzmann H, Hocker P, Gisslinger H, Barnas U.
Erythropoietin treatment of anaemia associated with multiple myeloma.
N Engl J Med.
1990;
322
1693-1699
-
10
Abels R I.
Recombinant human erythropoietin in the treatment of the anaemia of cancer.
Acta Haematol.
1992;
21
(S 3)
21-28
Korrespondenzadress
Chefarzt Dr. Andreas Jakob
Klinikum Offenburg
Medizinische Klinik II
Ebertplatz 12
77654 Offenburg
eMail: dr.jakob@gmx.net
